528 



IMMUNO-CATALYSIS 



Cocarboxylase— (Cont'ii) 

 a-keto-glutaric, 364 

 pyruvic dehydrogenase, 364, 372 

 pyruvic ketolase, 364 

 pyruvic dismutase, 368 

 Coenzyme(s), 99, 117-118 



cozymase I, II, 204, 363, 367, 370, 

 381 

 in muscle metabolism, 431 

 cocarboxylase in fermentation, 364 

 haptens, comparison with, 117-118 

 uridine-diphosphate-glucose, 98 

 coenzyme of galactowaldenase, 98 

 Coli, E., amino acid oxidase, 375 

 Clostridium 



aerofetidum, proteinase in, 262 

 hifermentans, proteinase in, 262 

 hotulinum, 3, 335—336 



toxin, lipase activity of, 335 

 action, nature of, 336 

 red blood cells, agglutination 



by, 336 

 resistance to proteinases, 336 

 type A crystalline, 335-336 

 proteinase in, 262 

 fallax, proteinase in, 262 

 histolyticum 



collagen, solubilizing action on, 



359 

 hyaluronidase in, 245 

 proteinase in, 179, 182, 245, 

 260-263 

 oedematiens (novyi) 

 hyaluronidase in, 232 

 proteinase in, 262 

 toxins of, 338-339, 351 

 oedematis-maligni (vibrion sep- 

 tique) 

 hyaluronidase in, 232, 236 

 proteinase in, 179, 261, 262 

 ovitoxicus 



hyaluronidase in, 232 

 proteinase in, 262 

 paludis 



hyaluronidase in, 232 



proteinase in, 262 

 futrificum, proteinase in, 262 

 se'pticum 



hemolytic toxin in, 319 

 hyaluronidase in, 243, 245, 248, 

 249 

 sordelli, proteinase in, 262 

 sporogenes, proteinase in, 182, 245, 



262 

 tetani, 3 



hyaluronidase in, 232 

 toxin, properties of crystalline, 

 336-337 

 welchii 



antitoxins, 357—361 

 antihemolysin and anti-lecithin- 

 ase, simultaneous action 

 on, 350 

 collagenase activity of, 359-361 

 enzymes of, 352—361 



antibody against, 352-361 

 fat-embolism caused by, 361 

 hyaluronidase production by, 

 232, 234, 237-238, 243, 

 248, 249, 360 

 lecithinase, activity of, 335, 339- 

 352, 358 

 biological effects, 350-352, 



358 

 characteristics of, 345 

 hemolysis, parallelism with, 



349 

 opalescence (in serum, vitel- 

 lin) caused by, 347-350 

 nature of, 347-348 

 pharmacological action, 355- 



357 

 production of, 351 

 quantitative methods, 345-350 

 substrates of, 344 



competition with anti- 

 lecithinase for, 361 

 lipase activity of, 335 

 pathological effects of toxins of, 

 357-361 



